The Use of Blood Biomarkers to Predict Poor Outcome After Acute Transient Ischemic Attack or Ischemic Stroke | Zendy

William Whiteley | Zendy; Joanna M. Wardlaw | Zendy; Martin Dennis | Zendy; Gordon Lowe | Zendy; Ann Rumley | Zendy; Naveed Sattar | Zendy; Paul Welsh | Zendy; Alison Green | Zendy; Mary Andrews | Zendy; Peter Sandercock | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Use of Blood Biomarkers to Predict Poor Outcome After Acute Transient Ischemic Attack or Ischemic Stroke

Author(s) -

William Whiteley,

Joanna M. Wardlaw,

Martin Dennis,

Gordon Lowe,

Ann Rumley,

Naveed Sattar,

Paul Welsh,

Alison Green,

Mary Andrews,

Peter Sandercock

Publication year - 2011

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.111.634089

Subject(s) - medicine , modified rankin scale , stroke (engine) , logistic regression , brain natriuretic peptide , cardiology , biomarker , natriuretic peptide , ischemic stroke , ischemia , heart failure , mechanical engineering , biochemistry , chemistry , engineering

The prediction of death or disability ("poor outcome") after stroke by validated clinical models might be improved by the addition of blood biomarker measurements. We investigated whether such measurements improved the classification of patients into 4 categories of predicted risk of poor outcome: very high, intermediate high, intermediate low, and very low.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research